Meridian to buy diagnostic bio component company:
This article was originally published in Clinica
Executive Summary
Meridian Bioscience of Cincinnati, Ohio, has agreed to acquire all outstanding capital stock of OEM Concepts, a developer of biological components used in diagnostic tests. These monoclonal antibodies, which generated over $4m in revenues for Toms-River, New Jersey-based OEM, are form an important component in diagnostic tools for infectious diseases and for monitoring metabolic disorders, pregnancy and cardiac disease. The transaction, which involves a mix of cash and milestone payments, is expected to close within 60-90 days.